Skip to content

Trial Summary

Clinical validation of circulating tumour DNA (ctDNA) mutation analysis by targeted NGS testing using FOLLOW IT in patients with solid tumours

Acronym:

FOLLOW-IT

ACTRN/NCT /ethics:

 

Scientific title:

Clinical validation of circulating tumour DNA (ctDNA) mutation analysis by targeted NGS testing using FOLLOW IT in patients with solid tumours

Sponsor / Cooperative group:

Sonic Genetics

Trial & Patient Characteristics

Cancer TypeAll cancers
Trial TypeTreatment
PhaseAll phases
Age Range18 years and older
SexBoth
Tumour Stream Solid Tumors
Cancer Stage-
Anticipated Start Date-
Anticipated End Date-

Participating Hospitals

HospitalAshford Cancer Centre Research
Clinical Trial CoordinatorSue Yeend
Emailsyeend@adelaidecancercentre.com.au
Phone08 8292 2240
Principal InvestigatorDr Caroline Bampton
Recruitment StatusRecruiting